Search Results - "Huff, A C"

Refine Results
  1. 1

    Epidemiology and Outcomes of Clostridium difficile Infections in Hematopoietic Stem Cell Transplant Recipients by Alonso, Carolyn D., Treadway, Suzanne B., Hanna, David B., Huff, Carol Ann, Neofytos, Dionissios, Carroll, Karen C., Marr, Kieren A.

    Published in Clinical infectious diseases (15-04-2012)
    “…Background. Clostridium difficile is the leading cause of infectious diarrhea among hospitalized patients and is a major concern for patients undergoing…”
    Get full text
    Journal Article
  2. 2

    Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen by Bolaños-Meade, J, Luznik, L, Muth, M, Matsui, W H, Huff, C A, Smith, B D, Levy, M Y, Kasamon, Y L, Swinnen, L J, Powell, J D, Brodsky, R A, Ambinder, R F, Jones, R J, Fuchs, E J

    Published in Bone marrow transplantation (Basingstoke) (01-03-2009)
    “…Graft failure after allogeneic blood or marrow transplantation, although generally uncommon, can be a devastating complication. This report includes the…”
    Get full text
    Journal Article
  3. 3

    Identification of control elements 3' to the human keratin 1 gene that regulate cell type and differentiation-specific expression by HUFF, C. A, YUSPA, S. H, ROSENTHAL, D

    Published in The Journal of biological chemistry (05-01-1993)
    “…To define DNA regulatory elements that mediate the response of the keratin 1 (K1) gene to Ca(2+)-induced differentiation, regions spanning the 5'- and…”
    Get full text
    Journal Article
  4. 4

    Characterization of clonogenic multiple myeloma cells by Matsui, William, Huff, Carol Ann, Wang, Qiuju, Malehorn, Matthew T., Barber, James, Tanhehco, Yvette, Smith, B. Douglas, Civin, Curt I., Jones, Richard J.

    Published in Blood (15-03-2004)
    “…The identity of the cells responsible for the initiation and maintenance of multiple myeloma (MM) remains unclear largely because of the difficulty growing MM…”
    Get full text
    Journal Article
  5. 5

    Recrudescence of Cutaneous Mycobacterium haemophilum Lesions Following Tetanus Immunization by Gibson, Michael K., Villano, Stephen A., Huff, Carol Ann

    Published in Clinical infectious diseases (01-04-1999)
    “…Mycobacterium haemophilum is increasingly recognized as a cause of cutaneous, joint, and pulmonary infections in immuno-compromised hosts. We describe a…”
    Get full text
    Journal Article Conference Proceeding
  6. 6

    Evidence for a common mechanism of action for antitumor and antibacterial agents that inhibit type II DNA topoisomerases by Huff, A C, Kreuzer, K N

    Published in The Journal of biological chemistry (25-11-1990)
    “…Numerous antitumor and antibacterial agents inhibit type II DNA topoisomerases, yielding, in each case, a complex of enzyme covalently bound to cleaved DNA. We…”
    Get full text
    Journal Article
  7. 7

    Autoproteolysis of the small subunit of calcium-dependent protease II activates and regulates protease activity by DeMartino, G N, Huff, C A, Croall, D E

    Published in The Journal of biological chemistry (15-09-1986)
    “…Calcium-dependent protease II (CDP-II) from bovine heart is a heterodimer with subunit molecular weights of 80,000 and 26,000. Previous studies have…”
    Get full text
    Journal Article
  8. 8

    DNA damage at thymine N-3 abolishes base-pairing capacity during DNA synthesis by Huff, A C, Topal, M D

    Published in The Journal of biological chemistry (15-09-1987)
    “…3-Methylthymine was synthesized into DNA copolymers and deoxynucleoside triphosphate to study its effect on DNA synthesis by the Klenow fragment of Escherichia…”
    Get full text
    Journal Article
  9. 9

    Bacteriophage T4 DNA Topoisomerase is the Target of Antitumor Agent 4′-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) in T4-Infected Escherichia coli by Huff, Anne C., Leatherwood, Janet K., Kreuzer, Kenneth N.

    “…The mammalian type II DNA topoisomerase has been proposed to be the intracellular target of a variety of antitumor agents, including m-AMSA…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Changes in Photo-Aged Human Skin Following Topical Application of All-Trans Retinoic Acid by Rosenthal, Dean S, Roop, Dennis R, Huff, Carol A, Weiss, Jonathan S, Ellis, Charles N, Hamilton, Ted, Voorhees, John J, Yuspa, Stuart H

    Published in Journal of investigative dermatology (01-11-1990)
    “…Although topical applications of retinoids on rodents and humans have been shown to cause epidermal hyperplasia, a detailed study of the influence of retinoids…”
    Get full text
    Journal Article
  12. 12

    DNA sequence preferences at sites cleaved by human DNA topoisomerase II in response to novel quinolone derivatives by Huff, A C, Robinson, R G, Evans, A C, Selander, K N, Wentland, M P, Rake, J B, Coughlin, S A

    Published in Anti-cancer drug design (01-04-1995)
    “…We have examined the DNA cleavage site specificity of human type II DNA topoisomerase in the presence of each of five novel quinolone derivatives. Each…”
    Get more information
    Journal Article
  13. 13

    Isolation and characterization of monoclonal antibodies to a recombinant human topoisomerase II polypeptide by Robinson, R G, Rapp, L, Bowdish, K J, Graham, M A, Huff, A C, Coughlin, S A

    Published in Hybridoma (01-08-1993)
    “…We have produced two murine monoclonal antibodies (SWT3D1 and SWR1C2) to a recombinant polypeptide corresponding to the carboxyl-terminal one-third (amino acid…”
    Get more information
    Journal Article
  14. 14

    A human epidermal differentiation-specific keratin gene is regulated by calcium but not negative modulators of differentiation in transgenic mouse keratinocytes by Rosenthal, D S, Steinert, P M, Chung, S, Huff, C A, Johnson, J, Yuspa, S H, Roop, D R

    Published in Cell growth & differentiation (01-02-1991)
    “…Keratins K1 and K10 represent the major differentiation products of the maturing epidermal keratinocytes. Primary epidermal cell cultures from newborn K1…”
    Get full text
    Journal Article
  15. 15
  16. 16

    The paradox of response and survival in cancer therapeutics by Huff, Carol Ann, Matsui, William, Smith, B. Douglas, Jones, Richard J.

    Published in Blood (15-01-2006)
    “…Although most patients with cancer respond to therapy, few are cured. Moreover, objective clinical responses to treatment often do not even translate into…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Effects of imatinib and interferon on primitive chronic myeloid leukaemia progenitors by Angstreich, Greg R., Matsui, William, Huff, Carol Ann, Vala, Milada S., Barber, James, Hawkins, Anita L., Griffin, Constance A., Douglas Smith, B., Jones, Richard J.

    Published in British journal of haematology (01-08-2005)
    “…Summary Imatinib has impressive activity against chronic myeloid leukaemia (CML), but does not appear to completely eradicate the disease. Although responses…”
    Get full text
    Journal Article
  19. 19

    Mutational alteration of the breakage/resealing subunit of bacteriophage T4 DNA topoisomerase confers resistance to antitumor agent m-AMSA by Huff, A C, Ward, 4th, R E, Kreuzer, K N

    Published in Molecular & general genetics (01-03-1990)
    “…Bacteriophage T4 provides a simple model system in which to examine the mechanism of action of antitumor agents that have been proposed to attack type II DNA…”
    Get more information
    Journal Article
  20. 20

    Strategies to eliminate cancer stem cells: Clinical implications by Huff, Carol Ann, Matsui, William H., Douglas Smith, B., Jones, Richard J.

    Published in European journal of cancer (1990) (01-06-2006)
    “…Over the past two decades, major advances in our understanding of cancer have translated into only modest increments in survival for the majority of cancer…”
    Get full text
    Journal Article